Temple University Health System

Temple University Health System

Temple University Health System was established in 1892 as the clinical arm of Temple University. Today it operates as a major academic health system, with Temple University as its sole corporate member. The system encompasses multiple hospitals, including Temple University Hospital—Main Campus, Fox Chase Cancer Center, Jeanes Campus, Episcopal Campus, and Chestnut Hill Hospital, all located in Philadelphia. The system employs over 1,700 physicians and researchers, making it one of the largest healthcare providers in the region. The health system's investment posture is inseparable from its clinical mission. It deploys capital into physical infrastructure, such as the Temple Women & Families Campus and a critical-care ground transport fleet, as well as research programs and clinical service lines. Temple University Hospital acts as a safety-net provider for North Philadelphia, meaning the system's endowment must absorb higher uncompensated-care costs than peers. The Fox Chase Cancer Center campus, acquired to expand oncology capabilities, now hosts a curated Healing Visual Arts Program Collection, signaling how the system blends capital allocation with patient experience. Governance runs through the Board of Trustees of Temple University, chaired by Mitchell L. Morgan, founder of Morgan Properties. President and CEO Michael A. Young leads day-to-day operations. Board members include Leonard Barrack of Barrack, Rodos & Bacine and Lon R. Greenberg, former chairman and CEO of UGI Corporation. The system also maintains two affiliated foundations—the Episcopal Health Care Foundation and the Temple University Health System Foundation—that channel philanthropic capital into care delivery and research. No dedicated investment team or separate endowment structure is publicly detailed. The system's structural differentiator is not an outsourced CIO model or a discretionary fund structure, but governance by the university's Board of Trustees, which blends academic oversight with clinical-operational responsibility. That hybrid governance means endowment investment decisions are not firewalled from the operating pressures of a safety-net hospital network, creating a capital-allocation dynamic distinct from a traditional university endowment that manages a liquid, diversified portfolio at arm's length from campus operations.